Financial Ratios

CORE HEALTHCARE LTD.

NSE : NABSE : 500091ISIN CODE : INE494A01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE6.870 (0 %)
PREV CLOSE ( ) 6.87
OPEN PRICE ( ) 6.67
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )6.67 7.30
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2007Mar2006Mar2005Mar2004Mar2003
Operational & Financial Ratios
   Earnings Per Share (Rs)0.35-19.09-42.95-43.97-28.21
   CEPS(Rs)0.68-6.35-29.39-30.03-14.24
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-42.18-367.81-348.71-299.51-249.91
   Tax Rate(%)0.88-0.030.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-41.28-9.4611.715.39
   EBIT Margin(%)-120.85-29.24-25.4113.69
   Pre Tax Margin(%)-123.77-138.48-121.80-57.80
   PAT Margin (%)-123.81-138.48-121.80-57.80
   Cash Profit Margin (%)-41.18-94.76-83.20-29.18
Performance Ratios
   ROA(%)0.27-7.20-15.33-14.95-9.29
   ROE(%)0.000.000.000.000.00
   ROCE(%)0.41-10.12-4.49-4.222.91
   Asset Turnover(x)0.000.060.110.120.16
   Sales/Fixed Asset(x)0.000.060.110.130.18
   Working Capital/Sales(x)0.0028.214.656.9932.16
Efficiency Ratios
   Fixed Capital/Sales(x)17.568.807.675.71
   Receivable days24.9721.8024.9516.93
   Inventory Days20.2624.0133.9528.83
   Payable days282.39185.63189.06148.54
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.00-0.89-0.51-0.13-0.25
   Price/Book(x)0.00-0.02-0.04-0.01-0.01
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)38.0218.6014.7010.08
   EV/Core EBITDA(x)9.90-92.94309.55107.6277.86
   EV/EBIT(x)151.17-29.40-61.30-55.8771.24
   EV/CE(x)13.162.132.041.781.58
   M Cap / Sales0.390.500.110.08
Growth Ratio
   Net Sales Growth(%)-100.00-51.78-14.26-26.2030.38
   Core EBITDA Growth(%)193.31-428.26-62.29-22.09-60.02
   EBIT Growth(%)101.93-105.501.14-237.3371.00
   PAT Growth(%)101.8355.552.32-55.8723.34
   EPS Growth(%)101.8355.552.32-55.8723.34
Financial Stability Ratios
   Total Debt/Equity(x)-1.06-1.48-1.55-1.70-1.89
   Current Ratio(x)0.131.031.491.301.07
   Quick Ratio(x)0.131.041.381.160.90
   Interest Cover(x)48.98-41.42-0.27-0.260.19
   Total Debt/Mcap(x)90.9034.42122.63124.89

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.